{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:09:34Z","timestamp":1780103374096,"version":"3.54.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.urolonc.2005.03.018","type":"journal-article","created":{"date-parts":[[2005,5,10]],"date-time":"2005-05-10T17:49:35Z","timestamp":1115747375000},"page":"56-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Promoting general health during androgen deprivation therapy (ADT): A rapid 10-step review for your patients"],"prefix":"10.1016","volume":"23","author":[{"given":"Mark A.","family":"Moyad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2005.03.018_bib1","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJM199912093412401","article-title":"Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer","volume":"341","author":"Messing","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2005.03.018_bib2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1056\/NEJM199707313370502","article-title":"Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin","volume":"337","author":"Bolla","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2005.03.018_bib3","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1210\/jc.2004-1611","article-title":"The influence of androgen deprivation therapy on metabolism in patients with prostate cancer","volume":"90","author":"Nishiyama","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.urolonc.2005.03.018_bib4","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1097\/01.ju.0000141820.17959.2f","article-title":"Osteoporosis and obesity in men receiving hormone therapy for prostate cancer","volume":"172","author":"Smith","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2005.03.018_bib5","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ucl.2004.01.001","article-title":"Understanding treatments for bone loss and bone metastases in patients with prostate cancer","volume":"31","author":"Higano","year":"2004","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.urolonc.2005.03.018_bib6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ucl.2004.03.006","article-title":"Lifestyle changes to prevent prostate cancer, part I","volume":"31","author":"Moyad","year":"2004","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.urolonc.2005.03.018_bib7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ucl.2004.03.007","article-title":"Lifestyle changes to prevent prostate cancer, part II","volume":"31","author":"Moyad","year":"2004","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.urolonc.2005.03.018_bib8","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1158\/1055-9965.644.13.4","article-title":"Soy isoflavones do not modulate prostate-specific antigen concentrations in older men in a randomized controlled trial","volume":"13","author":"Adams","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urolonc.2005.03.018_bib9","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/ajcn.81.2.397","article-title":"Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile","volume":"81","author":"Zhan","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.urolonc.2005.03.018_bib10","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1158\/1055-9965.340.13.3","article-title":"The role of tomato products and lycopene in the prevention of prostate cancer","volume":"13","author":"Etminan","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urolonc.2005.03.018_bib11","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1093\/jnci\/djh296","article-title":"Fruit and vegetable intake and risk of major chronic disease","volume":"96","author":"Hung","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2005.03.018_bib12","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1001\/archinte.164.21.2335","article-title":"The SU.VI.MAX Study","volume":"164","author":"Hercberg","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.urolonc.2005.03.018_bib13","first-page":"20","article-title":"Dietary supplements in primary care","volume":"59","author":"Ciocon","year":"2004","journal-title":"Geriatrics"},{"key":"10.1016\/j.urolonc.2005.03.018_bib14","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1001\/jama.286.2.208","article-title":"Herbal medicines and perioperative care","volume":"286","author":"Ang-Lee","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.urolonc.2005.03.018_bib15","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.1200\/JCO.2004.03.121","article-title":"Complementary and alternative medicine use by patients enrolled onto phase I clinical trials","volume":"22","author":"Dy","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2005.03.018_bib16","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1200\/JCO.2004.08.182","article-title":"Herbal remedies in the United States","volume":"22","author":"Sparreboom","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2005.03.018_bib17","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1001\/jama.293.11.1338","article-title":"Effects of long-term vitamin E supplementation on cardiovascular events and cancer","volume":"293","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.urolonc.2005.03.018_bib18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7326\/0003-4819-142-1-200501040-00110","article-title":"Meta-analysis","volume":"142","author":"Miller","year":"2005","journal-title":"Ann Intern Med"},{"issue":"suppl 4A","key":"10.1016\/j.urolonc.2005.03.018_bib19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0090-4295(01)01190-6","article-title":"Selenium and vitamin E supplements for prostate cancer","volume":"59","author":"Moyad","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2005.03.018_bib20","series-title":"The ABCs of nutrition and supplements for prostate cancer","author":"Moyad","year":"2000"},{"key":"10.1016\/j.urolonc.2005.03.018_bib21","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.urolonc.2004.10.001","article-title":"Why a statin and\/or another proven heart healthy agent should be utilized in the next major chemoprevention trial","volume":"22","author":"Moyad","year":"2004","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2005.03.018_bib22","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.urolonc.2004.10.002","article-title":"Why a statin and\/or another proven heart healthy agent should be utilized in the next major chemoprevention trial","volume":"22","author":"Moyad","year":"2004","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2005.03.018_bib23","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.urolonc.2004.10.005","article-title":"Improving overall men\u2019s health and potentially reducing the risk of certain cancers via serum markers and risk assessment for coronary heart disease","volume":"22","author":"Moyad","year":"2004","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2005.03.018_bib24","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/jnci\/97.5.330","article-title":"Cancer surpasses heart disease as leading cause of death for all but the very elderly","volume":"97","author":"Twombly","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2005.03.018_bib25","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1161\/01.CIR.0000035036.22612.2B","article-title":"The international burden of cardiovascular disease","volume":"106","author":"Bonow","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.urolonc.2005.03.018_bib26","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/jnci\/92.8.613","article-title":"Causes of death in elderly prostate cancer patients and in a comparison nonprostate cancer cohort","volume":"92","author":"Newschaffer","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2005.03.018_bib27","doi-asserted-by":"crossref","unstructured":"Katz MO, Zelefsky MJ, Marion C, et al. Statin use is associated with improved biochemical outcome after high-dose radiotherapy for clinically localized prostate cancer [abstract]. Proceedings of the 45th Annual ASTRO Meeting 2003:S271 [abstract 1016].","DOI":"10.1016\/S0360-3016(03)01114-3"},{"key":"10.1016\/j.urolonc.2005.03.018_bib28","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.urolonc.2005.03.018_bib29","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.urolonc.2005.03.018_bib30","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa042378","article-title":"C-reactive protein levels and outcomes after statin therapy","volume":"352","author":"Ridker","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2005.03.018_bib31","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.CIR.0000053730.47739.3C","article-title":"Clinical application of c-reactive protein for cardiovascular disease detection and prevention","volume":"107","author":"Ridker","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.urolonc.2005.03.018_bib32","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/jama.291.5.585","article-title":"C-reactive protein and the risk of incident colorectal cancer","volume":"291","author":"Erlinger","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.urolonc.2005.03.018_bib33","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3949\/ccjm.71.9.729","article-title":"Homocysteine","volume":"71","author":"Lentz","year":"2004","journal-title":"Clev Clin J Med"},{"key":"10.1016\/j.urolonc.2005.03.018_bib34","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa032546","article-title":"Homocysteine levels and the risk osteoporotic fracture","volume":"350","author":"van Meurs","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2005.03.018_bib35","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1056\/NEJMoa032739","article-title":"Homocysteine as a predictive factor for hip fracture in older persons","volume":"350","author":"McLean","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2005.03.018_bib36","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1001\/archinte.159.19.2349","article-title":"Effects on exercise training on older patients with major depression","volume":"159","author":"Blumenthal","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.urolonc.2005.03.018_bib37","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/00006842-200009000-00006","article-title":"Exercise treatment for major depression","volume":"62","author":"Babyak","year":"2000","journal-title":"Psychosom Med"},{"key":"10.1016\/j.urolonc.2005.03.018_bib38","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1200\/JCO.2003.09.534","article-title":"Resistance training in men receiving androgen deprivation therapy for prostate cancer","volume":"21","author":"Segal","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2005.03.018_bib39","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.urology.2003.11.009","article-title":"Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging","volume":"63","author":"Cavallini","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2005.03.018_bib40","first-page":"6","article-title":"Alternative therapies for reducing hot flashes in patients on luteinizing hormone-releasing hormone agonist treatment\/orchiectomy for prostate cancer","volume":"2","author":"Moyad","year":"2000","journal-title":"Grand Rounds in Urology"},{"issue":"Suppl 4A","key":"10.1016\/j.urolonc.2005.03.018_bib41","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0090-4295(02)01641-2","article-title":"Complementary\/alternative therapies for reducing hot flashes in prostate cancer patients","volume":"59","author":"Moyad","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2005.03.018_bib42","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2165\/00002512-200118080-00004","article-title":"Hot flashes","volume":"18","author":"Barton","year":"2001","journal-title":"Drugs Aging"},{"key":"10.1016\/j.urolonc.2005.03.018_bib43","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3949\/ccjm.71.7.578","article-title":"Treatment options for menopausal hot flashes","volume":"71","author":"Sikon","year":"2004","journal-title":"Clev Clin J Med"},{"key":"10.1016\/j.urolonc.2005.03.018_bib44","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/01.GME.0000108177.85442.71","article-title":"Treatment of menopause-associated vasomotor symptoms","volume":"11","year":"2004","journal-title":"Menopause"},{"key":"10.1016\/j.urolonc.2005.03.018_bib45","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ucl.2004.02.002","article-title":"The impact of osteoporosis in men treated for prostate cancer","volume":"31","author":"Oefelein","year":"2004","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.urolonc.2005.03.018_bib46","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ucl.2004.01.008","article-title":"Preventing male osteoporosis","volume":"31","author":"Moyad","year":"2004","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.urolonc.2005.03.018_bib47","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1097\/01.ju.0000141515.67372.e5","article-title":"The diagnosis and treatment of osteoporosis in men on androgen deprivation therapy for advanced carcinoma of the prostate","volume":"172","author":"Bae","year":"2004","journal-title":"J Urol"},{"issue":"suppl 10","key":"10.1016\/j.urolonc.2005.03.018_bib48","first-page":"S1","article-title":"2002 Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada","volume":"167","author":"Brown","year":"2002","journal-title":"CMAJ"},{"key":"10.1016\/j.urolonc.2005.03.018_bib49","series-title":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Report of a WHO Study Group. WHO Technical Report Series, 843","year":"1994"},{"issue":"suppl 4A","key":"10.1016\/j.urolonc.2005.03.018_bib50","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0090-4295(01)01174-8","article-title":"Complementary therapies for reducing the risk of osteoporosis in patients receiving luteinizing hormone-releasing hormone treatment\/orchiectomy for prostate cancer","volume":"59","author":"Moyad","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2005.03.018_bib51","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.urolonc.2005.03.018_bib52","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1301\/nr.2004.sept.354-359","article-title":"Hypovitaminosis D-induced pain","volume":"62","author":"Mascarenhas","year":"2004","journal-title":"Nutr Rev"},{"key":"10.1016\/j.urolonc.2005.03.018_bib53","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0022-5347(05)68001-9","article-title":"Treatment of vitamin D deficiency in patients with metastatic prostate cancer may improve bone pain and muscle strength","volume":"163","author":"Van Veldhuizen","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2005.03.018_bib54","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1001\/jama.291.16.1999","article-title":"Effect of vitamin D on falls","volume":"291","author":"Bischoff-Ferrari","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.urolonc.2005.03.018_bib55","first-page":"303","article-title":"Complications of androgen deprivation therapy","volume":"18","author":"Holzbeierlein","year":"2004","journal-title":"Oncology (Huntingt)"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143905000426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143905000426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T09:51:41Z","timestamp":1761040301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143905000426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S1078143905000426"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2005.03.018","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Promoting general health during androgen deprivation therapy (ADT): A rapid 10-step review for your patients","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2005.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}